Anika Therapeutics Reports Record Second Quarter Revenue and Earnings
16:05 EDT 1 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Anika
Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue
protection, healing, and repair, based on hyaluronic
acid (“HA”) technology, today reported financial results for the
quarter ended June 30, 201...
Other Sources for this Article
Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., 781-457-9000
CEO
or
Kevin
W. Quinlan, 781-457-9000
CFO
More From BioPortfolio on "Anika Therapeutics Reports Record Second Quarter Revenue and Earnings"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
